17 results
management diagnosis diabetes endocrinology treatment medications neurology rheumatology sglt2 syndrome abscess agonists allopurinol als amyotrophic anthracycline cardiology cardiotoxicity chemotherapy comparison
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
SGLT2 Inhibitors ... - Pharmacology ... Summary Mechanisms ... #Pharmacology # ... Summary #DM2 #diabetes
DPP-4 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
- Pharmacology ... Summary Mechanisms ... not definitively cause ... #Pharmacology # ... Summary #DM2 #diabetes
Metformin Pharmacology Summary Mechanisms of Action: • Suppresses gluconeogenesis by the liver • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... Summary Mechanisms ... agent • Does not cause ... side effects (e.g ... #Summary #DM2 #
Vasopressors and Inotropes - Pharmacology Summary Vasopressors Phenylephrine (alpha-1) • Increases BP, SVR • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Summary Vasopressors ... • Higher doses cause ... Phosphodiesterase inhibitor ... cAMP/cGMP • Causes
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... Summary Mechanisms ... side effects (e.g ... not definitively cause ... #Summary #DM2 #
SGLT2 Inhibitors SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... SGLT2 inhibitors ... kidney), which causes ... #Pharmacology # ... Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Medication Guide Classes ... α-glucosidase inhibitor ... 0.3-0.6 units/kg ... Diabetes #Mellitus #DM2 ... #Medications #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Drugs, Unknown cause ... Etoposide/VP16 (100 mg/m2 ... , ICU in case of ... Anti-IFN-y and JAK inhibitors ... management #treatment #summary
SAPHO Syndrome Summary What? SAPHO syndrome is a rare chronic inflammatory disorder of bone, joint, and skin characterized
SAPHO Syndrome Summary ... Rule out other causes ... antiinflammatory properties e.g ... , IL-17 inhibitors ... , and IL-23 inhibitors
Myasthenia Gravis - Summary • an autoimmune disease of the postsynaptic neuromuscular junction associated with antibodies
Myasthenia Gravis - Summary ... serologic, and EMG ... More likely to cause ... cholinesterase inhibitor ... glucocorticoids - can cause
No results found for "PocketCard ekg causes collateral pharmacology summary dm2 inhibitors"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #PocketCard #ekg #causes #collateral #pharmacology #summary #dm2 #inhibitors